FindTrial
Sign In

Study on the Influencing Factors of Postprandial Discomfort Syndrome and the Intervention Effect of Xiangsha Yangwei Pills

Study on the Influencing Factors of Postprandial Discomfort Syndrome and the Intervention Effect of Xiangsha Yangwei Pills

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100050304
Enrollment
Unknown
Registered
2021-08-26
Start date
2022-03-01
Completion date
Unknown
Last updated
2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postprandial malaise syndrome

Interventions

Therapy group:Xiangsha Yangwei pills
Positive control group:Domperidone tablets
Negative control group:Xiangsha Yangwei pill placebo

Sponsors

Hu'nan Academy of Traditional Chinese Medicine Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Meet the diagnostic criteria of PDS; 2.No medication for functional dyspepsia has been taken within half a month; 3.Aged 18 to 70 years.

Exclusion criteria

Exclusion criteria: 1.Helicobacter pylori gastritis is accompanied by dyspeptic symptoms, erosive gastritis, peptic ulcer, post-gallbladder syndrome, gastric cancer and some other secondary gastric dyskinesias (such as diabetic gastroparesis); 2.Patients with allergies or drug contraindications; 3.Patients with severe heart, brain, liver, kidney and other organ diseases; 4.Patients with mental illness; 5.Pregnant women and diabetic patients.

Design outcomes

Primary

MeasureTime frame
Efficacy observation index;Quality of life and its influencing factors;Safety observation index;—

Countries

China

Contacts

Public ContactHuang Yajuan

Hu'nan Academy of Traditional Chinese Medicine Affiliated Hospital

1370023019@qq.com+86 13739055748

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026